A study published in Psycho-Oncology found that from 21% to 25% of patients with breast cancer experienced cognitive impairment during and after treatment. Researchers reviewed 17 studies involving 1,978 breast cancer patients and found chemotherapy appeared to play a more significant role in cognitive dysfunction than radiotherapy and endocrine therapy.
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.